•Nonserious
nasopharyngeal adverse events
in Type 1 patients: inhaled insulin > SQ
•Nonserious
adverse events related to the ear
in pediatric patients:
inhaled insulin >
SQ
•Inhaled
insulin associated with greater insulin
antibody response than comparators,
but no apparent clinical correlate
over the period of observation
•